These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3104706)

  • 21. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P; Lee CC; Chen LF
    Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Min HQ
    J Clin Oncol; 2005 Feb; 23(6):1118-24. PubMed ID: 15657403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intensity-modulated radiation combined with Delisheng injection for naspharyngeal carcinoma].
    Zhao D; Liu XJ; Xie Q; Huang ZP; Zou BX; Ge YB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):874-5. PubMed ID: 16793625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
    Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
    Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal treatment for localized esophageal cancer still uncertain.
    Lord RV
    Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 10-year survival of nasopharyngeal carcinoma. A report of 1,302 cases.
    Zhang EP; Liang PG; Li ZQ; Cai GL; Chen YF; Cai MD; Zeng XF; Guan XX
    Chin Med J (Engl); 1987 May; 100(5):419-24. PubMed ID: 3115715
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study.
    Mäkitie AA; Reis PP; Irish J; Zhang T; Chin SF; Chen X; Marriott C; Keller A; Perez-Ordonez B; Kamel-Reid S; Siu LL
    Head Neck; 2004 Sep; 26(9):815-22. PubMed ID: 15350028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma.
    Farhat K; Hassen E; Gabbouj S; Bouaouina N; Chouchane L
    Int J Immunogenet; 2008 Jun; 35(3):197-205. PubMed ID: 18312596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
    Chua DT; Ma J; Sham JS; Mai HQ; Choy DT; Hong MH; Lu TX; Au GK; Min HQ
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1300-6. PubMed ID: 16750333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
    Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
    Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined treatment in carcinoma of the nasopharynx.
    Souhami L; Rabinowits M
    Laryngoscope; 1988 Aug; 98(8 Pt 1):881-3. PubMed ID: 3135458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
    Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combination treatment of late nasopharyngeal carcinoma: an analysis of short-term therapeutic results in 200 cases].
    Zhang S; Cai Y; Gu Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):70-2. PubMed ID: 8732120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central nervous system metastasis from nasopharyngeal carcinoma: a report of two patients and a review of the literature.
    Ngan RK; Yiu HH; Cheng HK; Chan JK; Sin VC; Lau WH
    Cancer; 2002 Jan; 94(2):398-405. PubMed ID: 11905411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-cytokine therapy for advanced renal cell carcinoma: determination of the minimal effective dose.
    Hamada I; Kato M; Okada K
    Anticancer Res; 2002; 22(4):2429-36. PubMed ID: 12174939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis].
    Wang CT; Cao KJ; Li Y; Xie GF; Huang PY
    Ai Zheng; 2007 Feb; 26(2):212-5. PubMed ID: 17298756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of hypopharyngeal cancer responding to recombinant interferon-gamma (KW-2202)].
    Enomoto T; Nakanishi H; Iwasaki D
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):536-9. PubMed ID: 3101610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.